# ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

> **NCT03685045** · NA · RECRUITING · sponsor: **Kirby Institute** · enrollment: 6000 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **PROCEDURE:** Campaign days

## Key facts

- **NCT ID:** NCT03685045
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-05-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2026-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03685045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03685045, "ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03685045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*